Cargando…
A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion
Autores principales: | Elkady, Djoni, Okorie, Chiamaka L., Estupiñan, Blanca, Modi, Mitul B., Cotler, Scott J., Lake, Eden |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458671/ https://www.ncbi.nlm.nih.gov/pubmed/37635861 http://dx.doi.org/10.1016/j.jdcr.2023.07.025 |
Ejemplares similares
-
Reactivation of Human Herpesvirus (HHV) 6 as Etiology of Acute Liver Injury in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report
por: Li, Jonathan C
Publicado: (2022) -
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016) -
Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review
por: Zhu, Harrison, et al.
Publicado: (2023) -
Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012) -
Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer
por: Cornell, Seth L., et al.
Publicado: (2014)